A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Sentinel lymph node mapping in endometrial cancer: an updated review
2022
Hong Kong Journal of Gynaecology, Obstetrics and Midwifery
lymph node mapping (SLNM) is widely used in staging of both low-and high-risk early-stage endometrial cancer. It has a high detection rate, high sensitivity, high negative predictive value, and low false negative rate in detection of lymph node metastasis. Cervical injection of indocyanine green for SLNM is the preferred method. SLNM reduces the number of lymph node removal and reduces complications from lymphadenectomy without compromising oncological safety. This review discusses the latest
doi:10.12809/hkjgom.22.2.08
fatcat:zweqj5iewvhg7ayha52nrpsbnm